Pausa pranzo - SocietÃ italiana di neurologia

More documents

Recommendations

Info

SI RINGRAZIANO PER LA PARTECIPAZIONE ALLERGAN PHARMACEUTICAL IRELAND ALMIRALL SPA A.C.R. ANGELINI FRANCESCO SPA ASTELLAS PHARMA SPA ATES MEDICA DEVICE SRL BAYER SCHERING PHARMA BIOGEN-DOMPÉ SRL R I N G R A Z I A M E N T I BOEHRINGER INGELHEIM ITALIA SPA CARE FUSION ITALY 237 SRL CHIESI FARMACEUTICI SPA EB NEURO SPA EDIZIONI MEDICO E PAZIENTI EISAI SRL ELI LILLY ITALIA SPA EMS SRL EPITECH GROUP SRL GE HEALTHCARE SRL GENZYME SRL GLAXOSMITHKLINE SPA IPSEN SPA ISTITUTO LUSOFARMACO D'ITALIA SPA JANSSEN CILAG SPA LABOREST ITALIA SPA LUNDBECK ITALIA SPA MEDA PHARMA SPA MERCK SERONO SPA MICROMED SPA 224
NIHON KOHDEN ITALIA SRL NOVARTIS FARMA SPA PFIZER ITALIA SRL PHARMAVAL SRL SANOFI-AVENTIS SPA SERVIER SPA SHIRE ITALIA SPA - HUMAN GENETIC THERAPIES SPRINGER VERLAG ITALIA SRL SR LABS SRL UCB PHARMA SPA VECCHI & PIAM S.A.P.A. R I N G R A Z I A M E N T I 225
Page 1:
XLI Congresso Società Italiana di
Page 7 and 8:
Sotto l’Alto Patronato della Pres
Page 9 and 10:
CONSIGLIO DIRETTIVO SIN Presidente
Page 11 and 12:
BREVE STORIA DI CATANIA Seconda cit
Page 13:
AZIENDE ESPOSITRICI 13 Allergan Pha
Page 16 and 17:
SABATO 23 OTTOBRE TEATRO “MASSIMO
Page 18 and 19:
09.00 11.00 11.30 13.30 13.30 14.30
Page 20 and 21:
24 O T T O B R E • A U D I T O R
Page 22 and 23:
24 O T T O B R E • S A L A D E M
Page 24 and 25:
24 O T T O B R E • S A L A A L C
Page 26 and 27:
24 O T T O B R E • S A L A P I T
Page 28 and 29:
24 O T T O B R E • S A L A F I L
Page 30 and 31:
24 O T T O B R E • CASI CLINICI:
Page 32 and 33:
24 O T T O B R E • CONFERENZA DID
Page 34 and 35:
Page 36 and 37:
24 O T T O B R E • SIMPOSIO ore 1
Page 38 and 39:
24 O T T O B R E • S A L A A R C
Page 40 and 41:
Page 42 and 43:
24 O T T O B R E • S A L A SIMPOS
Page 44 and 45:
24 O T T O B R E • S A L A E M P
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
24 O T T O B R E • S A L A P A U
Page 52 and 53:
24 O T T O B R E • S A L A GRUPPO
Page 54 and 55:
LUNEDI 25 OTTOBRE AUDITORIUM SALA E
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
25 O T T O B R E • S A L A A C R
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
25 O T T O B R E • CASI CLINICI I
Page 68 and 69:
Page 70 and 71:
25 O T T O B R E • S A L A CONFER
Page 72 and 73:
25 O T T O B R E • SIMPOSIO CONGI
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
25 O T T O B R E • GRUPPO DI STUD
Page 82 and 83:
Page 84 and 85:
25 O T T O B R E • S A L A ASSOCI
Page 86 and 87:
25 O T T O B R E • S A L A P A U
Page 88 and 89:
Page 90 and 91:
09.00 11.00 11.30 13.30 13.30 14.30
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
26 O T T O B R E • S A L A A C R
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
26 O T T O B R E • CORSO ore 14.3
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
8.30 10.30 11.30 13.30 AUDITORIUM S
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
27 O T T O B R E • S A L A GRUPPO
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142:
27 O T T O B R E • CHIUSURA DEI L
Page 145 and 146:
11. BMAA EFFECTS ON SUBSTANTIA NIGR
Page 147 and 148:
37. MARKERS OF LGG MALIGNANT DEGENE
Page 149 and 150:
DEMENZA ED INVECCHIAMENTO 1 Moderat
Page 151 and 152:
OF COMPLETE ATRIOVENTRICULAR BLOCK:
Page 153 and 154:
110. EVALUATION OF BDNF GENE AS RIS
Page 155 and 156:
133. THE CLINICAL PICTURE OF PERSIS
Page 157 and 158:
158. A FAMILY AFFECTED BY PRIMARY F
Page 159 and 160:
PERFORMANCE: AN IN VIVO FMRI INVEST
Page 161 and 162:
210. SENSORIMOTOR RHYTHM-BASED BRAI
Page 163 and 164:
CERAVOLO, S. ROSSI, D. MAFFEI, H. S
Page 165 and 166:
252. MUTATIONAL ANALYSIS OF THE DCX
Page 167 and 168:
L. MERICO, M. ACQUAVIVA, A. PANARO,
Page 169 and 170:
298. DIAGNOSTIC CRITERIA FOR THE DI
Page 171 and 172:
EPILESSIA 1 Moderatori V. SOFIA (Ca
Page 173 and 174:
348. FUNCTIONING AND DISABILITY IN
Page 175 and 176: MALATTIE DEL MOTONEURONE Moderatori
Page 177 and 178: 397. FUS GENE ANALYSIS IN AN ITALIA
Page 179 and 180: 420. INCREASE OF RECENTLY-RELEASED
Page 181 and 182: POSTER ore 16.30 - 17.30 DISORDINI
Page 183 and 184: 459. AMYGDALAR LOCAL STRUCTURAL DIF
Page 185 and 186: M. VALERIANI, S. TARANTINO, C. VOLL
Page 187 and 188: HEMOGLOBIN SATURATION IN MILD COGNI
Page 189 and 190: M. PRONTERA, M. ELIA, G. BOERO, G.
Page 191 and 192: F. PESCINI, F. CESARI, B. GIUSTI, J
Page 193 and 194: IN STROKE PATIENTS S. VIDALE, C. DE
Page 195 and 196: 604. EARLY RECOGNITION OF MEMORY IM
Page 197 and 198: 628. VALUATION OF HEMATOPOIETIC STE
Page 199 and 200: 652. DIRECT MEDICAL COST OF PATIENT
Page 201 and 202: POSTER ore 10.30 - 11.30 DISORDINI
Page 203 and 204: NEUROIMMUNOLOGIA Moderatori P. ANNU
Page 205 and 206: 709. WHITE MATTER ARCHITECTURE AND
Page 207 and 208: 732. FUNCTIONAL NEUROIMAGING CORREL
Page 209 and 210: NEUROSCIENZE DI BASE Moderatori D.
Page 211 and 212: 785. LAMBERT-EATON MYASTENIC SYNDRO
Page 213 and 214: 809. BK CHANNEL BETA4 SUBUNIT GENE
Page 215 and 216: 830. RANDOMIZED PLACEBO-CONTROLLED
Page 217 and 218: 854. FATIGUE IN MULTIPLE SCLEROSIS
Page 219 and 220: 878. HEALTH PROFESSIONALS’ PERSPE
Page 221 and 222: pagnatori o gli eventuali interessa
Page 223 and 224: ECM ● ISTRUZIONI Al Vostro arrivo
Page 225: In particolare, dei 150 crediti del
Page 229 and 230: Catania Centro Congressuale Le Cimi
Page 231 and 232: Catania Centro Congressuale Le Cimi
Page 236: SEGRETERIA ORGANIZZATIVA SIN Studio
show all

Pausa pranzo - SocietÃ italiana di neurologia

Create successful ePaper yourself

Delete template?

Save as template?